☆ 4.4 Review

Hidradenitis Suppurativa in Children and Adolescents: An Update on Pharmacologic Treatment Options

PEDIATRIC DRUGS (2023)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials

Alexa B. Kimball et al.

Summary: Two randomized trials showed that secukinumab was clinically effective at rapidly improving signs and symptoms of moderate-to-severe hidradenitis suppurativa with a favorable safety profile and sustained response up to 52 weeks of treatment.

LANCET (2023)

Add to Collection

Review Dermatology

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience

Fabrizio Martora et al.

Summary: To date, adalimumab is the only approved biotechnology drug for managing hidradenitis suppurativa (HS), but its efficacy in real-life practice varies. This review analyzes the current evidence on the use of biologics in HS, particularly adalimumab, secukinumab, ustekinumab, and ixekizumab. While the results are promising, more studies are needed. The armamentarium of drugs for HS management is expanding, allowing for personalized treatment approaches to minimize adverse events.

CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2023)

Add to Collection

Article Dermatology

Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action study

Koen Dudink et al.

Summary: 65% of patients with moderate-to-severe hidradenitis suppurativa achieved a clinical response after 16 weeks of guselkumab treatment, which was well tolerated. Transcriptomic data supported the rationale for IL-23 inhibition with guselkumab, but did not consistently correlate with protein expression and clinical responses. Guselkumab seems to be beneficial only in a subgroup of HS patients, suggesting that the IL-23/T helper 17 axis is not central to the pathophysiology of HS.

BRITISH JOURNAL OF DERMATOLOGY (2023)

Add to Collection

Article Dermatology

Pediatric hidradenitis suppurativa: Describing care patterns in the emergency department

Raphaella A. A. Lambert et al.

Summary: This study compared the care received by pediatric hidradenitis suppurativa (HS) patients in the emergency department (ED) with treatment guidelines and the management of pediatric skin and soft tissue abscess (SSTA) patients. A retrospective chart review of 58 HS and 175 SSTA patients revealed that SSTA patients more frequently received incision and drainage (I&D) and oral clindamycin treatment in the ED. Improving knowledge of pediatric HS treatment among ED physicians is recommended to address these differences.

PEDIATRIC DERMATOLOGY (2023)

Add to Collection

Article Dermatology

Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study

Lawrence F. Eichenfield et al.

Summary: This study investigated the efficacy and safety of IDP-126 in children and adolescents with moderate-to-severe acne. The results showed that IDP-126 demonstrated superior efficacy in treatment success, lesion reduction, and improvement in Acne-Specific Quality of Life compared to the vehicle and three dyad component gels. It was also well tolerated.

PEDIATRIC DERMATOLOGY (2023)

Add to Collection

Review Dermatology

Efficacy of procedural treatments for pediatric hidradenitis suppurativa: A systematic review

Rahul Masson et al.

Summary: Hidradenitis suppurativa (HS) is a painful, inflammatory skin disease that has been understudied in the pediatric population. Procedural interventions, such as surgical excisions, skin grafts, and lasers, are important for managing HS. However, there is a lack of data on procedural treatments for HS in pediatric patients. This systematic review aims to evaluate the efficacy and safety of procedural treatments for HS in pediatric patients and highlights the need for randomized controlled trials to guide treatment decisions.

PEDIATRIC DERMATOLOGY (2023)

Add to Collection

Article Dermatology

Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial

Alexa B. Kimball et al.

Summary: This study evaluated the efficacy and safety of risankizumab in the treatment of moderate-to-severe hidradenitis suppurativa (HS). The results showed that risankizumab is not an effective treatment for moderate-to-severe HS.

DERMATOLOGY AND THERAPY (2023)

Add to Collection

Letter Dermatology

Dapsone therapy for hidradenitis suppurativa: a retrospective review of characteristics and treatment outcomes in a cohort of 122 patients in a tertiary dermatology setting

Mia Steyn et al.

BRITISH JOURNAL OF DERMATOLOGY (2023)

Add to Collection

Review Dermatology

Hidradenitis suppurativa in pediatric patients

Ellie Choi et al.

Summary: Interest and research in hidradenitis suppurativa (HS) have grown in the past decade, expanding knowledge about associated comorbidities and treatment efficacy. Limited understanding exists about pediatric-onset HS, but with increasing prevalence of childhood obesity and awareness of HS, physicians may encounter younger HS patients more frequently.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

Add to Collection

Article Dermatology

Pediatric Hidradenitis Suppurativa: A Cross-Sectional Study on Clinical Features and Treatment Approaches

Simone Garcovich et al.

Summary: Pediatric hidradenitis suppurativa presents a clinical spectrum comparable to adult-onset disease, with key risk factors being patient's age and BMI. Compared to the general hidradenitis suppurativa population, adolescent patients are more likely to exhibit obesity and smoking as risk factors.

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2022)

Add to Collection

Review Dermatology

Biologic Use in Pediatric Patients With Hidradenitis Suppurativa: A Systematic Review

Muskaan Sachdeva et al.

Summary: This study analyzed the outcomes of biologic therapy in 26 pediatric patients with HS, finding that anti-TNF alpha inhibitors were the most commonly used biologics. Approximately 73% of patients experienced partial resolution, around 23% had complete resolution, and no adverse events were reported.

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2022)

Add to Collection

Letter Dermatology

Trends in the prescribing pattern of spironolactone for acne and hidradenitis suppurativa in adolescents

Mikael Horissian et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

Add to Collection

Review Dermatology

Treatment Outcomes of IL-17 Inhibitors in Hidradenitis Suppurativa: A Systematic Review

Nadia Kashetsky et al.

Summary: IL-17 inhibitors may be an effective therapeutic target in approximately two-thirds of patients with HS and can be considered in those who are refractory to other treatment modalities. Consistent outcome measures are important to enhance evidence synthesis, decrease reporting bias, provide potential for future meta-analysis, and ultimately improve clinical outcomes for patients with HS.

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2022)

Add to Collection

Letter Dermatology

Pediatric hidradenitis suppurativa: epidemiology, disease presentation, and treatments

Justine Seivright et al.

JOURNAL OF DERMATOLOGICAL TREATMENT (2022)

Add to Collection

Review Biochemistry & Molecular Biology

New and Emerging Targeted Therapies for Hidradenitis Suppurativa

Adela Markota Cagalj et al.

Summary: This review examines the evidence for emerging therapies targeting the main pro-inflammatory cytokines in Hidradenitis suppurativa (HS). The most promising biologics in phase III trials are anti-IL-17 antibodies, secukinumab, and bimekizumab. An anti-IL-1 biologic, bermekimab, is currently in phase II trials and shows encouraging results. However, the clinical efficacies of all new targeted therapies published up to this point are limited, and more studies are needed to evaluate the efficacy of biological therapies for HS.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Pediatrics

The impact of a multidisciplinary care package for vaccination in needle phobic children: An observational study

Rebecca Doyle et al.

Summary: This study assessed the impact of a multidisciplinary, consumer-oriented model of care on vaccinations for children with severe needle phobia. The results showed that an individualized, collaborative approach is preferable to a 'one size fits all' model of care.

JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2022)

Add to Collection

Review Multidisciplinary Sciences

Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis

Ying Xi et al.

Summary: This study conducted a systematic review and meta-analysis to identify factors independently predicting multidrug-resistant tuberculosis (MDR-TB). The results revealed that positive sputum acid-fast bacilli (AFB) smear, lung cavity, previous TB disease, and a history of anti-TB therapy were significant risk factors for MDR-TB. These findings have important implications for global TB control.

PLOS ONE (2022)

Add to Collection

Article Dermatology

Evaluation of Hidradenitis Suppurativa Diagnostic Criteria in Pediatric Patients

Nicole W. Kittler et al.

Summary: This retrospective study examined the diagnosis of pediatric patients with HS. The results showed that approximately 40% of the 297 adolescent HS patients did not meet all major diagnostic criteria at the time of diagnosis, largely due to failure to fulfill the 6-month recurrence interval criterion.

JAMA DERMATOLOGY (2022)

Add to Collection

Review Pediatrics

Effectiveness of ertapenem for treatment of infections in children: An evidence mapping and meta-analysis

Ruiqiu Zhao et al.

Summary: This study assessed the effectiveness and safety of ertapenem for treating childhood infections and found that it had similar treatment success rates as beta-lactam antibiotics. In terms of adverse events, there was no significant difference between ertapenem and other carbapenems or non-carbapenems.

FRONTIERS IN PEDIATRICS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

The Role of Hormones in Hidradenitis Suppurativa: A Systematic Review

Nessr Abu Rached et al.

Summary: This article introduces the pathogenesis of hidradenitis suppurativa (HS), in which hormones play an important role. Research has shown that HS patients have dysregulated adipokines and insulin resistance, leading to more severe cardiovascular diseases. Androgens also play an important role in certain female patients. Anti-androgen therapy may be helpful for some patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Dermatology

Management of adolescents with hidradenitis suppurativa

Erin Collier et al.

Summary: HS can significantly impact the quality of life for adolescents, particularly in terms of self-esteem, body image, and sexual maturation. Physician intervention may be necessary to address social challenges related to school, relationships, and employment faced by teenage HS patients. Comprehensive management strategies for this special group include improving medication adherence, screening for comorbidities, and recommending practical lifestyle modifications to reduce disease flares.

JOURNAL OF DERMATOLOGICAL TREATMENT (2021)

Add to Collection

Article Dermatology

Use of spironolactone to treat acne in adolescent females

Erin E. Roberts et al.

Summary: This study found that spironolactone is effective in treating acne in adolescent females with a favorable side effect profile. It can be considered as a safe long-term alternative to systemic antibiotics for these patients.

PEDIATRIC DERMATOLOGY (2021)

Add to Collection

Review Respiratory System

Multidrug-resistant tuberculosis in children and adolescents: current strategies for prevention and treatment

James A. Seddon et al.

Summary: The diagnosis and treatment of multidrug-resistant tuberculosis in children have historically been neglected, leading to a low proportion of diagnosed and treated cases. However, recent developments in diagnostic and therapeutic approaches have improved pediatric management. Further research and evidence-based practices are needed to enhance prevention and treatment strategies for children with MDR-TB.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2021)

Add to Collection

Article Dermatology

Dapsone in hidradenitis suppurativa: A case series of 56 patients

Cristina Lopez-Llunell et al.

Summary: Dapsone, as a third-line treatment for HS, showed good effectiveness and tolerability in this study, mainly chosen for patients with LC2 phenotype. In the study, 62.5% of patients achieved HiSCR after 12 weeks of treatment.

DERMATOLOGIC THERAPY (2021)

Add to Collection

Letter Dermatology

Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa in patients of paediatric age: a pilot prospective study

V. Bettoli et al.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Add to Collection

Editorial Material Dermatology

Intralesional Triamcinolone for Hidradenitis Suppurativa-How Much Is Needed?

Dittle M. L. Saunte et al.

DERMATOLOGIC SURGERY (2021)

Add to Collection

Article Dermatology

Hidradenitis Suppurativa in the Pediatric Population An International, Multicenter, Retrospective, Cross-sectional Study of 481 Pediatric Patients

Carmen Liy-Wong et al.

Summary: The study highlighted a gap in recognizing and diagnosing pediatric HS, with pediatric patients likely to present with other comorbidities. More prospective observational and interventional studies are needed to better understand the clinical course and optimal treatments for pediatric HS.

JAMA DERMATOLOGY (2021)

Add to Collection

Article Emergency Medicine

Caring for Pediatric Hidradenitis Suppurativa Patients in the Emergency Department

Kavina Patel et al.

Summary: The article offers recommendations for managing children with acute HS flares, aiming to educate clinicians on specific considerations in caring for these patients.

PEDIATRIC EMERGENCY CARE (2021)

Add to Collection

Article Dermatology

Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial

Sophie Glatt et al.

Summary: In this study, bimekizumab showed clinically meaningful improvements in patients with moderate to severe HS, demonstrating greater efficacy compared to placebo. The safety profile of bimekizumab was consistent with previous studies, supporting further evaluation for HS treatment.

JAMA DERMATOLOGY (2021)

Add to Collection

Article Dermatology

Metformin use in hidradenitis suppurativa

Lorraine Jennings et al.

JOURNAL OF DERMATOLOGICAL TREATMENT (2020)

Add to Collection

Article Dermatology

Intralesional Triamcinolone for Fistulous Tracts in Hidradenitis Suppurativa: An Uncontrolled Prospective Trial with Clinical and Ultrasonographic Follow-Up

Pedro Alvarez et al.

DERMATOLOGY (2020)

Add to Collection

Review Dermatology

The impact of chronic skin disease in adolescence and the need for specialist adolescent services

I. J. De Vere Hunt et al.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2020)

Add to Collection

Article Dermatology

Ustekinumab with Intravenous Infusion: Results in Hidradenitis Suppurativa

Jorge Romani et al.

DERMATOLOGY (2020)

Add to Collection

Article Dermatology

Intralesional Triamcinolone May Not Be Beneficial for Treating Acute Hidradenitis Suppurativa Lesions: A Double-Blind, Randomized, Placebo-Controlled Trial

Kristen Fajgenbaum et al.

DERMATOLOGIC SURGERY (2020)

Add to Collection

Review Dermatology

Weight Loss and Dietary Interventions for Hidradenitis Suppurativa: A Systematic Review

Arunima Sivanand et al.

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2020)

Add to Collection

Letter Dermatology

Association between obesity and hidradenitis suppurativa among children and adolescents: A population-based analysis in the United States

Amrita Balgobind et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

Add to Collection

Letter Dermatology

Hidradenitis suppurativa management using tumor necrosis factor inhibitors in patients younger than 18 years: A series of 12 cases

Anne-Claire Fougerousse et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

Add to Collection

Article Dermatology

Weight counseling in pediatric hidradenitis suppurativa patients

Barbara Reichert et al.

PEDIATRIC DERMATOLOGY (2020)

Add to Collection

Article Dermatology

Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients

Peter Theut Riis et al.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2020)

Add to Collection

Review Dermatology

Medical and Surgical Management of Hidradenitis Suppurativa: A Review of International Treatment Guidelines and Implementation in General Dermatology Practice

Lauren A. Orenstein et al.

DERMATOLOGY (2020)

Add to Collection

Review Pediatrics

The Use of TNFα Inhibitors in Treating Pediatric Skin Disorders

Quoc-Bao D. Nguyen et al.

PEDIATRIC DRUGS (2020)

Add to Collection

Article Dermatology

New-onset depression among children, adolescents, and adults with hidradenitis suppurativa

Shari Wright et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

Add to Collection

Review Nursing

The fear of needles: A systematic review and meta-analysis

Jennifer McLenon et al.

JOURNAL OF ADVANCED NURSING (2019)

Add to Collection

Article Dermatology

North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part II: Topical, intralesional, and systemic medical management

Ali Alikhan et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)

Add to Collection

Article Dermatology

Combination hyperbaric oxygen therapy and ustekinumab for severe hidradenitis suppurativa

Lauren E. Provini et al.

PEDIATRIC DERMATOLOGY (2019)

Add to Collection

Review Pharmacology & Pharmacy

2 Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms

John W. Frew et al.

THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2019)

Add to Collection

Article Dermatology

Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials

G. B. E. Jemec et al.

BRITISH JOURNAL OF DERMATOLOGY (2019)

Add to Collection

Article Dermatology

Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology

Renata Ferreira Magalhaes et al.

ANAIS BRASILEIROS DE DERMATOLOGIA (2019)

Add to Collection

Article Dermatology

Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines

A. Offidani et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)

Add to Collection

Review Dermatology

Combination Therapies for Hidradenitis Suppurativa: A Retrospective Chart Review of 31 Patients

Meghan L. McPhie et al.

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2019)

Add to Collection

Article Dermatology

Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations

Raffaele Dante Caposiena Caro et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)

Add to Collection

Letter Dermatology

The effect of antimicrobial washes on antibacterial resistance in hidradenitis suppurativa lesions

Paul Leiphart et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)

Add to Collection

Review Medicine, Research & Experimental

Systematic review of immunomodulatory therapies for hidradenitis suppurativa

Shi Yu Derek Lim et al.

BIOLOGICS-TARGETS & THERAPY (2019)

Add to Collection

Article Dermatology

Hidradenitis suppurativa in a prepubertal girl

Sofia Lopes et al.

ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA (2019)

Add to Collection

Article Dermatology

A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa

Clio Dessinioti et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2018)

Add to Collection

Article Rheumatology

Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis

Vanessa Cecchin et al.

JOURNAL OF RHEUMATOLOGY (2018)

Add to Collection

Article Dermatology

Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents

Hannu Tiri et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)

Add to Collection

Letter Dermatology

Topical 15% resorcinol for hidradenitis suppurativa: An uncontrolled prospective trial with clinical and ultrasonographic follow-up

Jose C. Pascual et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

Add to Collection

Article Dermatology

Hidradenitis Suppurativa in Children Treated with Finasteride-A Case Series

Fernando Mota et al.

PEDIATRIC DERMATOLOGY (2017)

Add to Collection

Article Dermatology

A New Perspective on Isotretinoin Treatment of Hidradenitis Suppurativa: A Retrospective Chart Review of Patient Outcomes

Christina M. Huang et al.

DERMATOLOGY (2017)

Add to Collection

Review Dermatology

Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment

Maddalena Napolitano et al.

CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2017)

Add to Collection

Article Infectious Diseases

Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients

Olivier Join-Lambert et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)

Add to Collection

Article Dermatology

Cyclosporine treatment of severe Hidradenitis suppurativa - A case series

Marianne D. Anderson et al.

JOURNAL OF DERMATOLOGICAL TREATMENT (2016)

Add to Collection

Article Dermatology

Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum

J. L. Blok et al.

BRITISH JOURNAL OF DERMATOLOGY (2016)

Add to Collection

Article Dermatology

The use of intravenous ertapenem in the management of severe hidradenitis suppurativa

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)

Add to Collection

Article Medicine, General & Internal

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa

Alexa B. Kimball et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Add to Collection

Article Dermatology

Risk of Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Hidradenitis Suppurativa

Alexander Egeberg et al.

JAMA DERMATOLOGY (2016)

Add to Collection

Letter Dermatology

Hidradenitis suppurativa-acne inversa: a relevant dermatosis in paediatric patients

V. Bettoli et al.

BRITISH JOURNAL OF DERMATOLOGY (2015)

Add to Collection

Letter Dermatology

Prepubertal onset of hidradenitis suppurativa in a girl: A case report and literature review

Jelena M. Stojkovic-Filipovic et al.

INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2015)

Add to Collection

Article Pathology

The risk of copper deficiency in patients prescribed zinc supplements

Andrew Duncan et al.

JOURNAL OF CLINICAL PATHOLOGY (2015)

Add to Collection

Article Pediatrics

No Visible Dental Staining in Children Treated with Doxycycline for Suspected Rocky Mountain Spotted Fever

Suzanne R. Todd et al.

JOURNAL OF PEDIATRICS (2015)

Add to Collection

Article Dermatology

Hidradenitis suppurativa in the pediatric population

Carmen Liy-Wong et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)

Add to Collection

Article Dermatology

Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement

Inge E. Deckers et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)

Add to Collection

Article Dermatology

European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa

C. C. Zouboulis et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)

Add to Collection

Article Dermatology

Use of biological treatments in patients with hidradenitis suppurativa

G. Martin-Ezquerra et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)

Add to Collection

Article Urology & Nephrology

The Clinical Efficacy and Safety of Ertapenem for the Treatment of Complicated Urinary Tract Infections Caused by ESBL-Producing Bacteria in Children

Ayse Karaaslan et al.

INTERNATIONAL JOURNAL OF NEPHROLOGY (2015)

Add to Collection

Article Dermatology

Acitretin treatment for hidradenitis suppurativa: a prospective series of 17 patients

L. Matusiak et al.

BRITISH JOURNAL OF DERMATOLOGY (2014)

Add to Collection

Letter Dermatology

Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients

V. Bettoli et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)

Add to Collection

Review Pediatrics

Hidradenitis Suppurativa in Children and Adolescents: A Review of Treatment Options

Peter Riis Mikkelsen et al.

PEDIATRIC DRUGS (2014)

Add to Collection

Article Dermatology

Metformin for the treatment of hidradenitis suppurativa: a little help along the way

R. Verdolini et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)

Add to Collection

Article Pediatrics

Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne

Lawrence F. Eichenfield et al.

PEDIATRICS (2013)

Add to Collection

Article Dermatology

Finasteride for the Treatment of Hidradenitis Suppurativa in Children and Adolescents

Harkamal Kaur Randhawa et al.

JAMA DERMATOLOGY (2013)

Add to Collection

Article Urology & Nephrology

Persistent Sexual Side Effects of Finasteride: Could They Be Permanent?

Michael S. Irwig

JOURNAL OF SEXUAL MEDICINE (2012)

Add to Collection

Article Medicine, General & Internal

Hidradenitis Suppurativa

Gregor B. E. Jemec

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Add to Collection

Article Dermatology

Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer?

J. Boer et al.

BRITISH JOURNAL OF DERMATOLOGY (2011)

Add to Collection

Article Dermatology

Dapsone Therapy for Hidradenitis Suppurativa: A Series of 24 Patients

Shiva Yazdanyar et al.

DERMATOLOGY (2011)

Add to Collection

Article Dermatology

Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa

J. Boer et al.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2010)

Add to Collection

Article Dermatology

Infliximab therapy for patients with moderate to severe hidradenitis, suppurativa: A randomized, double-blind, placebo-controlled crossover trial

Annika Grant et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)

Add to Collection

Article Immunology

Pharmacokinetics and Tolerability of Single-dose Intravenous Ertapenem in Infants, Children, and Adolescents

Susan M. Abdel-Rahman et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)

Add to Collection

Article Dermatology

Absence of Efficacy of Oral Isotretinoin in Hidradenitis Suppurativa: A Retrospective Study Based on Patients' Outcome Assessment

A. Soria et al.

DERMATOLOGY (2009)

Add to Collection

Article Infectious Diseases

Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection

Adriano Arguedas et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)

Add to Collection

Review Dermatology

Hidradenitis suppurativa: A comprehensive review

Ali Alikhan et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)

Add to Collection

Article Dermatology

Hidradenitis Suppurativa in 64 female patients: Retrospective study comparing oral antibiotics and antiandrogen therapy

John N. Kraft et al.

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2007)

Add to Collection

Article Pediatrics

Absence of tooth staining with doxycycline treatment in young children

Benjamin Volovitz et al.

CLINICAL PEDIATRICS (2007)

Add to Collection

Article Dermatology

Hidradenitis suppurativa and zinc:: A new therapeutic approach -: A pilot study

Anabelle Brocard et al.

DERMATOLOGY (2007)

Add to Collection

Article Endocrinology & Metabolism

Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: Improvement in body composition and fasting insulin

Shubha Srinivasan et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)

Add to Collection

Article Oncology

Dapsone therapy for children with immune thrombocytopenic purpura

ND Meeker et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.